Narendra Duhita

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The utility of plants as biofactories has progressed in recent years. Some recombinant plant-derived pharmaceutical products have already reached the marketplace. However, with the exception of drugs and vaccines, a strong effort has not yet been made to bring recombinant products to market, as cost-effectiveness is critically important for(More)
  • 1